Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- ALMKT.PA
- Price
- 0.12
- Stock movement up
- +- (%)
- Company name
- Mauna Kea Technologies SAS
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Markkapitalisasie
- 8.77M
- Ondernemingswaarde
- -
- Prys/Verkope
- -
- Prys/Boek
- -
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- -
- Volgende P/E
- -
- PEG
- -
- EPS groei
- -
- 1 jaar opbrengs
- -70.50%
- 3 jaar opbrengs
- -48.11%
- 5 jaar opbrengs
- -37.64%
- 10 jaar opbrengs
- -27.66%
Laaste opgedateer: 2025-09-15
DIVIDENDE
ALMKT.PA betaal nie dividende nie of geen data is ontvang nie
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | - |
| Prys tot OCF | - |
| Prys tot FCF | - |
| Prys tot EBITDA | - |
| EV tot EBITDA | - |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | - |
| Prys tot Boekwaarde | - |
| EV tot verkope | - |
FINANSIËLE
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 0.11 |
| Daaglikse hoog | 0.11 |
| Daaglikse laag | 0.10 |
| Daaglikse volume | 9K |
| Hoogtepunt van alle tye | 17.75 |
| 1j analiseraaming | 1.00 |
| Beta | 1.07 |
| EPS (TTM) | - |
| Dividend per aandeel | - |
| Ex-dividend datum | - |
| Volgende verdienste datum | 2 Oct 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| ALMKT.PA | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -99.41% | -0.80% |
| Hoogste prysdaling | -99.58% | -56.47% |
| Datum van hoogste daling | 28 Apr 2025 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -78.42% | -10.99% |
| Gemiddelde tyd tot nuwe hoogtepunt | 723 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 3612 days | 1805 days |
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
8.77M
Markkapitalisasie kategorie
Small-cap
Beskrywing
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Werknemers
65
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
France
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
PARIS & BOSTON, October 21, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
21 Oktober 2025
PARIS & BOSTON, October 13, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
13 Oktober 2025
PARIS & BOSTON, October 08, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
8 Oktober 2025
PARIS & BOSTON, October 06, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT):
6 Oktober 2025
PARIS, October 02, 2025--Regulatory News: Mauna Kea Technologies (Paris:ALMKT):
2 Oktober 2025
PARIS & BOSTON, October 01, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (...
1 Oktober 2025
PARIS & BOSTON, September 22, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), (the "Company") inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal lase...
22 September 2025
PARIS & BOSTON & SYDNEY, September 18, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT) and Endotherapeutics, today announced that Cellvizio system has been included in the Austr...
18 September 2025
PARIS & BOSTON, September 12, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy...
12 September 2025
PARIS & BOSTON, September 08, 2025--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy...
8 September 2025
Volgende bladsy